- Advocacy in Action: Our latest efforts on drug pricing, EDCs, physician payment and more...
- Oral Complications Are Rare in Older Women Treated for Osteoporosis—Study finds oral side effects are uncommon and manageable...
- Researchers Provide Baseline Characteristics of Infants with Atypical Genital Development
- Automatic for the (Lab) People: Embracing Automation in the Lab—New products are helping to bring the modern lab into the realm of science fiction of yesteryear as automation slowly but surely makes its way to the bench.
- Meet your 2019 Laureates
- ENDO Preview: Transgender Basics and Beyond
ENDO First Time Attendees
ENDO 2019 is right around the corner, and for some, it can be an overwhelming experience. If this will be your first Endocrine Society Annual Meeting, check out the resources we have compiled and the events we have planned for First Time Attendees.
Before you head to New Orleans, tune into episode 11 of the Endocrine News Podcast, where R. Michael Tuttle, MD, gives insight into how first-time attendees and trainees can navigate the meeting.
Use the ENDO 2019 Meeting Planner to create a customized meeting experience that is catered to your specific interests.
Finally, plan to attend the first-time attendee events to mingle with other first-timers and get the most out of your ENDO experience. We look forward to welcoming you to ENDO 2019!
Did your membership expire December 31?
Renew now before you lose access to your exclusive member benefits!
What is your experience with outpatient referrals from primary care providers? We encourage practicing endocrinologists to respond to this anonymous 10-12 minute research survey from an American College of Physicians and Veterans Health Administration (ACP/VA) research collaboration.
These results showed that the steroidogenic capacity decreased without histological change (the first hit) and declined with histological change (the second hit). Thus, we visualized the two-hit hypothesis in the adrenal cortex.
Our practical and objective method to assess pubertal status based on height velocity and growth chart trajectory highlights growth as a reliable and objective bioassay for pubertal onset, status, and progression.
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
This review summarizes what is known about FGF21 in mice and humans with a special focus on this factor’s role in glucose and lipid metabolism and in metabolic diseases, such as obesity and type 2 diabetes mellitus.
This study demonstrates that spheroids in ascites express and secrete FSH, which regulates cancer cell proliferation and spheroidogenesis through Notch signaling, suggesting that FSH is an autocrine regulator of cancer metastasis. Furthermore, Notch and FSHR are potential immunotherapeutic targets for ovarian cancer treatment.